Baldwin Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,500
| Closed | -$148K | – | 778 |
|
|
2023
Q3 | $148K | Hold |
14,500
| – | – | 0.01% | 254 |
|
|
2023
Q2 | $109K | Hold |
14,500
| – | – | 0.01% | 310 |
|
|
2023
Q1 | $128K | Hold |
14,500
| – | – | 0.01% | 290 |
|
|
2022
Q4 | $132K | Hold |
14,500
| – | – | 0.01% | 281 |
|
|
2022
Q3 | $117K | Hold |
14,500
| – | – | 0.02% | 223 |
|
|
2022
Q2 | $109K | Hold |
14,500
| – | – | 0.01% | 245 |
|
|
2022
Q1 | $136K | Hold |
14,500
| – | – | 0.01% | 245 |
|
|
2021
Q4 | $116K | Hold |
14,500
| – | – | 0.01% | 245 |
|
|
2021
Q3 | $141K | Hold |
14,500
| – | – | 0.02% | 230 |
|
|
2021
Q2 | $144K | Buy |
+14,500
| New | +$144K | 0.02% | 231 |
|
|
2017
Q3 | – | Sell |
-147
| Closed | -$5K | – | 502 |
|
|
2017
Q2 | $5K | Hold |
147
| – | – | ﹤0.01% | 446 |
|
|
2017
Q1 | $5K | Hold |
147
| – | – | ﹤0.01% | 451 |
|
|
2016
Q4 | $5K | Hold |
147
| – | – | ﹤0.01% | 473 |
|
|
2016
Q3 | $7K | Sell |
147
-125
| -46% | -$5.95K | ﹤0.01% | 477 |
|
|
2016
Q2 | $14K | Hold |
272
| – | – | ﹤0.01% | 370 |
|
|
2016
Q1 | $15K | Buy |
+272
| New | +$15K | ﹤0.01% | 385 |
|